A comprehensive genome-wide analysis of long non-coding RNA and mRNA expression profiles of JAK2V617F-positive classical myeloproliferative neoplasms

References

• Bose P, Nazha A, Komrokji RS, et al. Mutational landscape of myelodysplastic/myeloproliferative neoplasm-unclassifiable. Blood. 2018;132(19):2100–2103.
   Web of Science ®Google Scholar
• Merlinsky TR, Levine RL, Pronier E. Unfolding the role of calreticulin in myeloproliferative neoplasm pathogenesis. Clin Cancer Res. 2019;25(10):2956–2962.
   PubMed Web of Science ®Google Scholar
• Mead AJ, Mullally A. Myeloproliferative neoplasm stem cells. Blood. 2017;129(12):1607–1616.
   PubMed Web of Science ®Google Scholar
• James C, Ugo V, Le Couédic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature. 2005;434(7037):1144–1148.
   Web of Science ®Google Scholar
• Xu J, Bai J, Zhang X, et al. A comprehensive overview of lncRNA annotation resources. Brief Bioinform. 2017. DOI:10.1093/bib/bbw015.
   Web of Science ®Google Scholar
• Wang P, Xu J, Wang Y, et al. An interferon-independent lncRNA promotes viral replication by modulating cellular metabolism. Science. 2017;358(6366):1051–1055.
   Web of Science ®Google Scholar
• Zhao W, Geng D, Li S, et al. LncRNA HOTAIR influences cell growth, migration, invasion, and apoptosis via the miR-20a-5p/HMGA2 axis in breast cancer. Cancer Med. 2018. DOI:10.1002/cam4.1353
   Web of Science ®Google Scholar
• Yildirim E, Kirby JE, Brown DE, et al. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell. 2013;152(4):727–742.
   PubMed Web of Science ®Google Scholar
• Guo G, Kang Q, Zhu X, et al. A long noncoding RNA critically regulates Bcr-Abl-mediated cellular transformation by acting as a competitive endogenous RNA. Oncogene. 2015;34(14):1768–1779.
   Web of Science ®Google Scholar
• Lin J, Ma JC, Yang J, et al. Arresting of miR-186 and releasing of H19 by DDX43 facilitate tumorigenesis and CML progression. Oncogene. 2018;37(18):2432–2443.
   Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Ma W, Wang M, Wang ZQ, et al. Effect of long-term storage in TRIzol on microarray-based gene expression profiling. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2445–2452.
   Web of Science ®Google Scholar
• Barallon R, Bauer SR, Butler J, et al. Recommendation of short tandem repeat profiling for authenticating human cell lines, stem cells, and tissues. In Vitro Cell Dev Biol Anim. 2010;46(9):727–732.
   PubMed Web of Science ®Google Scholar
• Zahurak M, Parmigiani G, Yu W, et al. Pre-processing Agilent microarray data. BMC Bioinformatics. 2007;8(1). DOI:10.1186/1471-2105-8-142
   PubMedGoogle Scholar
• Chapman JR, Waldenström J. With reference to reference genes: a systematic review of endogenous controls in gene expression studies. PLoS One. 2015. DOI:10.1371/journal.pone.0141853
   Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• R Core Team. R: a language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; 2021. Available from: https://www.R-project.org/
   Google Scholar
• Cuadros M, García DJ, Andrades A, et al. LncRNA-mRNA Co-Expression Analysis Identifies AL133346.1/CCN2 as biomarkers in pediatric B-cell acute lymphoblastic leukemia. Cancers (Basel). 2020;12(12):3803.
   Web of Science ®Google Scholar
• Malcolm Perry. 2021. heatmaps: flexible heatmaps for functional genomics and sequence features. R package version 1.16.0.
   Google Scholar
• Huang Da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009. DOI:10.1038/nprot.2008.211
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223–227.
   Web of Science ®Google Scholar
• Wang Y, Liu CL, Storey JD, et al. Precision and functional specificity in mRNA decay. Proc Natl Acad Sci U S A. 2002. DOI:10.1073/pnas.092538799
   Web of Science ®Google Scholar
• Chen S, Dong C, Qian X, et al. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy. J Diabetes Complications. 2017;31(3):569–576.
   Web of Science ®Google Scholar
• Reimand J, Isserlin R, Voisin V, et al. Pathway enrichment analysis and visualization of omics data using g: profiler,GSEA, cytoscape and EnrichmentMap. Nat Protoc. 2019;14(2):482–517.
   PubMed Web of Science ®Google Scholar
• Quentmeier H, Geffers R, Jost E, et al. SOCS2: inhibitor of JAK2V617F-mediated signal transduction. Leukemia. 2008;22(12):2169–2175.
   Web of Science ®Google Scholar
• Ishibashi T, Yokota T, Tanaka H, et al. ESAM is a novel human hematopoietic stem cell marker associated with a subset of human leukemias. Exp Hematol. 2016;44(4):269–281.e1.
   Web of Science ®Google Scholar
• Spijkers-Hagelstein JA, Pinhanços SS, Schneider P, et al. Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL. Leukemia. 2014;28(4):761–769.
   PubMed Web of Science ®Google Scholar
• Alimam S, Villiers W, Dillon R, et al. Patients with triple-negative, JAK2 V617F- and CALR -mutated essential thrombocythemia share a unique gene expression signature. Blood Adv. 2021;5(4):1059–1068.
   PubMed Web of Science ®Google Scholar
• Ureshino H, Shindo T, Kojima H, et al. Allelic polymorphisms of KIR s and HLA s predict favorable responses to tyrosine kinase inhibitors in CML. Cancer Immunol Res. 2018;6(6):745–754.
   PubMed Web of Science ®Google Scholar
• Ponatinib circumvents FGF2-driven resistance to imatinib in CML. Cancer Discov. 2014. DOI:10.1158/2159-8290.cd-rw2014-016
   Google Scholar
• Vainchenker W, Kralovics R. Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms. Blood. 2017;129(6):667–679.
   Web of Science ®Google Scholar
• Klampfl T, Gisslinger H, Harutyunyan AS, et al. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013;369(25):2379–2390.
   PubMed Web of Science ®Google Scholar
• Marin Oyarzún CP, Heller PG. Platelets as mediators of thromboinflammation in chronic myeloproliferative neoplasms. Front Immunol. 2019;10. DOI:10.3389/fimmu.2019.01373.
   PubMed Web of Science ®Google Scholar
• Fan H, Lu J, Guo Y, et al. BAHCC1 binds H3K27me3 via a conserved BAH module to mediate gene silencing and oncogenesis. Nat Genet. 2020;52(12):1384–1396.
   Web of Science ®Google Scholar
• Tabilio A, Rosa JP, Testa U, et al. Expression of platelet membrane glycoproteins and alpha-granule proteins by a human erythroleukemia cell line (HEL). Embo J. 1984;3(2):453–459.
   PubMed Web of Science ®Google Scholar
• Hsu LI, Briggs F, Shao X, et al. Pathway analysis of genome-wide association study in childhood leukemia among hispanics. Cancer Epidemiol Biomarkers Prev. 2016;25(5):815–822.
   Web of Science ®Google Scholar
• Mercer TR, Mattick JS. Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol. 2013;20(3):300–307.
   PubMed Web of Science ®Google Scholar
• Dal Molin A, Hofmans M, Gaffo E, et al. CircRNAs dysregulated in juvenile myelomonocytic leukemia: circMCTP1 stands out. Front Cell Dev Biol. 2020. DOI:10.3389/fcell.2020.613540.
   PubMed Web of Science ®Google Scholar
• Zhu C, Kong Z, Wang B, et al. ITGB3/CD61: a hub modulator and target in the tumor microenvironment. Am J Transl Res. 2019; 11(12):7195-7208.
   Web of Science ®Google Scholar
• Nurden AT, Pillois X. ITGA2B and ITGB3 gene mutations associated with Glanzmann thrombasthenia. Platelets. 2018;29(1):98–101.
   Web of Science ®Google Scholar
• Nurden P, Stritt S, Favier R, et al. Inherited platelet diseases with normal platelet count: phenotypes, genotypes and diagnostic strategy. Haematologica. 2021. DOI:10.3324/haematol.2020.248153
   PubMed Web of Science ®Google Scholar
• Wende H, Colonna M, Ziegler A, et al. Organization of the leukocyte receptor cluster (LRC) on human chromosome 19q13.4. Mamm Genome. 1999. DOI:10.1007/s003359900961
   PubMed Web of Science ®Google Scholar
• Thananchai H, Gillespie G, Martin MP, et al. Cutting Edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J Immunol. 2007;178(1):33–37.
   PubMed Web of Science ®Google Scholar
• Castaño-Núñez Á, Montes-Cano MA, García-Lozano JR, et al. Association of functional polymorphisms of KIR3DL1/DS1 with Behçet’s Disease. Front Immunol. 2019;10. DOI:10.3389/fimmu.2019.02755.
   PubMed Web of Science ®Google Scholar
• Boudreau JE, Giglio F, Gooley TA, et al. KIR3DL1 / HL A-B subtypes govern acute myelogenous leukemia relapse after hematopoietic cell transplantation. J Clin Oncol. 2017;35(20):2268–2278.
   PubMed Web of Science ®Google Scholar
• Boudreau JE, Mulrooney TJ, Le Luduec JB, et al. KIR3DL1 and HLA-B density and binding calibrate NK education and response to HIV. J Immunol. 2016;196(8):3398–3410.
   Web of Science ®Google Scholar
• Ureshino H, Shindo T, Tanaka H, et al. HLA polymorphisms are associated with treatment-free remission following discontinuation of tyrosine kinase inhibitors in chronic myeloid leukemia. Mol Cancer Ther. 2021;20(1):142–149.
   Web of Science ®Google Scholar
• Schönberg K, Rudolph J, Vonnahme M, et al. JAK inhibition impairs NK cell function in myeloproliferative neoplasms. Cancer Res. 2015;75(11):2187–2199.
   PubMed Web of Science ®Google Scholar
• Jensen MK, De Nully Brown P, Lund BV, et al. Increased circulating platelet-leukocyte aggregates in myeloproliferative disorders is correlated to previous thrombosis, platelet activation and platelet count. Eur J Haematol. 2001;66(3):143–151.
   PubMed Web of Science ®Google Scholar
• Kovačić M, Mitrović-Ajtić O, Beleslin-Čokić B, et al. TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms. Cell Oncol (Dordr). 2018;41(5):541–553.
   PubMed Web of Science ®Google Scholar
• Yan P, Luo S, Lu JY, et al. Cis- and trans-acting lncRNAs in pluripotency and reprogramming. Curr Opin Genet Dev. 2017;46:170–178.
   PubMed Web of Science ®Google Scholar
• Kalsoom UE, Klopocki E, Wasif N, et al. Whole exome sequencing identified a novel zinc-finger gene ZNF141 associated with autosomal recessive postaxial polydactyly type A. J Med Genet. 2013;50(1):47–53.
   PubMed Web of Science ®Google Scholar
• Pisareva VP, Pisarev AV. DHX29 reduces leaky scanning through an upstream AUG codon regardless of its nucleotide context. Nucleic Acids Res. 2016;44(9):4252–4265.
   PubMed Web of Science ®Google Scholar
• Chapman NH, Bernier RA, Webb SJ, et al. Replication of a rare risk haplotype on 1p36.33 for autism spectrum disorder. Hum Genet. 2018;137(10):807–815.
   PubMed Web of Science ®Google Scholar
• Ling H, Vincent K, Pichler M, et al. Junk DNA and the long non-coding RNA twist in cancer genetics. Oncogene. 2015;34(39):5003–5011.
   Web of Science ®Google Scholar
• Mao C, Wang X, Liu Y, et al. A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 2018;canres.3454.2017. DOI:10.1158/0008-5472.can-17-3454.
   Web of Science ®Google Scholar
• Broux M, Prieto C, Demeyer S, et al. Suz12 inactivation cooperates with JAK3 mutant signaling in the development of T-cell acute lymphoblastic leukemia. Blood. 2019;134(16):1323–1336.
   PubMed Web of Science ®Google Scholar
• Guan C, Shi H, Wang H, et al. CtBP2 contributes to malignant development of human esophageal squamous cell carcinoma by regulation of p16 INK4A. J Cell Biochem. 2013;114(6):1343–1354.
   Web of Science ®Google Scholar
• Lee ST, Muench MO, Fomin ME, et al. Epigenetic remodeling in B-cell acute lymphoblastic leukemia occurs in two tracks and employs embryonic stem cell-like signatures. Nucleic Acids Res. 2015;43(5):2590–2602.
   Web of Science ®Google Scholar
• Martinez P, Amemiya CT. Genomics of the HOX gene cluster. Comp Biochem Physiol B Biochem Mol Biol. 2002;133(4):571–580.
   PubMed Web of Science ®Google Scholar
• Andreeff M, Ruvolo V, Gadgil S, et al. HOX expression patterns identify a common signature for favorable AML. Leukemia. 2008;22(11):2041–2047.
   Web of Science ®Google Scholar
• Tao YF, Fang F, Hu SY, et al. Hypermethylation of the GATA binding protein 4 (GATA4) promoter in Chinese pediatric acute myeloid leukemia. BMC Cancer. 2015;15(1). DOI:10.1186/s12885-015-1760-5
   Google Scholar
• Huet S, Dulucq S, Chauveau A, et al. Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts. Genes Chromosomes Cancer. 2015;54(10):595–605.
   PubMed Web of Science ®Google Scholar
• Reid AG, Nacheva EP. A potential role for PRDM12 in the pathogenesis of chronic myeloid leukaemia with derivative chromosome 9 deletion. Leukemia. 2004;18(1):178–180.
   Web of Science ®Google Scholar
• Schaller L, Lauschke VM. The genetic landscape of the human solute carrier (SLC) transporter superfamily. Hum Genet. 2019. DOI:10.1007/s00439-019-02081-x
   PubMed Web of Science ®Google Scholar
• Liu X. SLC family transporters. Adv Exp Med Biol. 2019. DOI:10.1007/978-981-13-7647-4_3
   Web of Science ®Google Scholar
• Papaioannou VE. The T-box gene family: emerging roles in development, stem cells and cancer. Development. 2014;141(20):3819–3833.
   PubMed Web of Science ®Google Scholar
• Pan CM, Chan KH, Chen CH, et al. MicroRNA-7 targets T-Box 2 to inhibit epithelial-mesenchymal transition and invasiveness in glioblastoma multiforme. Cancer Lett. 2020;493. DOI:10.1016/j.canlet.2020.08.024.
   Web of Science ®Google Scholar
• Chen SY, Zhu YT, Zhang Y, et al. HC-HA/PTX3 from amniotic membrane reverts senescent limbal niche cells to Pax6+ neural crest progenitors to support limbal epithelial progenitors. Stem Cells. 2020. DOI:10.1002/stem.3323
   Web of Science ®Google Scholar
• Rabiee B, Anwar KN, Shen X, et al. Gene dosage manipulation alleviates manifestations of hereditary PAX6 haploinsufficiency in mice. Sci Transl Med. 2020;12(573). DOI:10.1126/scitranslmed.aaz4894
   PubMed Web of Science ®Google Scholar
• Zhang XH, Li BF, Ding J, et al. LncRNA DANCR-miR-758-3p-PAX6 molecular network regulates apoptosis and autophagy of breast cancer cells. Cancer Manag Res. 2020. DOI:10.2147/cmar.s254069.
   Web of Science ®Google Scholar